Find Your Perfect GLP-1 Program

No. Food noise and constant hunger aren’t character flaws—they’re biological signals that are dysregulated. GLP-1s treat the underlying biology, just like blood pressure medication treats hypertension. You wouldn’t call taking heart medication cheating. This is medical treatment for a medical condition.

There are a few different GLP-1 drugs approved for weight loss. The most common are Wegovy (semaglutide) and Zepbound (tirzepatide). Older options like Saxenda (liraglutide) are still used but require daily injections instead of weekly ones. New medications such as retatrutide are also being studied and could be next in line for approval.

The GLP-1 that currently works best for weight loss is Zepbound (tirzepatide). In clinical trials, participants lost an average of around 20% of their total body weight, which is higher than any other approved medication. Wegovy (semaglutide) ranks second at around 15%. Both are highly effective, but tirzepatide’s dual action on two hormone pathways gives it a slight edge for stronger, faster, and more consistent results.

A GLP-1 receptor agonistu is a type of medication that mimics a natural hormone in your body called glucagon-like peptide-1 (GLP-1). This hormone helps regulate blood sugar, slows digestion, and signals fullness after eating. By activating these same receptors, GLP-1 drugs like Ozempic, Wegovy, and Zepbound help reduce appetite, improve blood sugar control, and support long-term weight loss.

Ozempic is not made from lizard venom, but it was inspired by it. The first GLP-1 drug, exenatide (Byetta), was developed after scientists discovered a compound in the saliva of the Gila monster, a venomous desert lizard. The compound acted like the body’s natural GLP-1 hormone but lasted longer, helping regulate blood sugar. That finding became the foundation for today’s GLP-1 medications, including Ozempic and Wegovy.

Tirzepatide and retatrutide are very similar, but retatrutide works on one extra hormon. Tirzepatide targets two hormones that help control hunger and blood sugar. Retatrutide targets three, which may help the body burn more fat In studies, people lost about 20% of their body weight on tirzepatide and around 24% on retatrutide, so it may be the stronger option that’s approved in the future.

GLP-1 medications can be used for childhood obesity in very specific situations. The FDA has approved liraglutide (Saxenda) and semaglutide (Wegovy) for obesity in children ages 12 and older. The European Medicines Agency has approved Mounjaro for type 2 diabetes in children ages 10 and up. Pediatric care is different from adult care and always centers on growth, development, adequate energy intake, and building healthy habits that support a child’s long-term well-being. Decisions about GLP-1 medications for children should always be made with qualified healthcare providers.